Clinical Trials Logo

Colitis clinical trials

View clinical trials related to Colitis.

Filter by:

NCT ID: NCT04999241 Not yet recruiting - Ulcerative Colitis Clinical Trials

Combined Application of EEN in the Induction of Remission in PUC

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease had been well documented. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week12 will be compared between the two groups (combine with EEN group VS non-combine group).

NCT ID: NCT04939025 Not yet recruiting - Ulcerative Colitis Clinical Trials

Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC

MIRACLE
Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The objective of this quality improvement project is to increase the one year anastomotic integrity rate in patients having had completion proctectomy and pouch reconstruction for Ulcerative Colitis by the routine and quality controlled implementation of a multi-interventional program thereby improving long-term pouch function and survival.

NCT ID: NCT04926103 Not yet recruiting - Clinical trials for Ulcerative Colitis Flare

Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis

FUEL
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The investigators intend to screen for new donors, given that there may a donor effect (PubMed ID: 25857665), with some donors not inducing remission in any patient whilst others inducing remission in 20-40% of cases. It is important to give UC patients participating in RCTs stool that has been demonstrated to be effective in some patients. We therefore propose to conduct an open label study in patients with active UC to ensure new donors are effective at inducing remission in some patients. Patients that have FMT will relapse within 18 months (PubMed ID: 25857665) although further FMT therapy induces remission so it is possible that maintenance FMT will result in long term remission, but this needs evaluation. We will therefore follow UC patients that have responded to FMT long term in this open label study.

NCT ID: NCT04882566 Not yet recruiting - Ulcerative Colitis Clinical Trials

Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease

Start date: August 2021
Phase:
Study type: Observational

Patients with inflammatory bowel disease (IBD) are increasingly becoming interested in nonpharmacologic approaches to their disease. One of the most frequently asked questions of IBD patients is what they should eat. The role of diet has become very important in the prevention and treatment of IBD. Although there is a general lack of rigorous scientific evidence that demonstrates which diet is best for certain patients, several diets have become popular. Aim of the Work To assess IBD patients' knowledge about the role of nutrition in the management of their Inflammatory Bowel Disease and the dietary beliefs, behaviors, and daily dietary practices in adult IBD patients that they make to avoid exacerbation of disease symptoms or to gain more control of bowel symptoms, keeping in mind our traditional and oriental food and food habits in Egypt. Also to evaluate the role of one of the most common dietary regimens; the Paleolithic diet in active mild or moderate inflammatory bowel disease.

NCT ID: NCT04818788 Not yet recruiting - Ulcerative Colitis Clinical Trials

Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis

Start date: April 1, 2021
Phase:
Study type: Observational

Investigators aimed at investigating the prediction ability of faecal calprotectin to predict mucosal healing and histological remission in ulcerative colitis patients receiving biological therapy Investigators aimed to evaluate the prediction ability of NLR, PLR and MLR to predict mucosal healing and histological remission in ulcerative colitis patients receiving biological therapy. Investigators evaluate the histological remission in ulcerative colitis patients receiving biological therapy in Assuit university hospital.

NCT ID: NCT04750135 Not yet recruiting - Ulcerative Colitis Clinical Trials

Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis

Start date: February 7, 2021
Phase: Phase 2
Study type: Interventional

Brief Summary: This is a randomized, controlled study evaluating metformin tablets administered daily for 8 weeks. The purpose of the study is to evaluate the efficacy and safety of metformin in the treatment of mild to moderately active ulcerative colitis. Disease activity will be measured using Mayo score for ulcerative colitis activity. Calculation of the score requires patients to undergo colonoscopy at the start of the study and at week 8.

NCT ID: NCT04670250 Not yet recruiting - Clinical trials for IBD, Non Invasive Markers,IL6,Lactoferrin,Ferritin

The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis

Start date: June 2021
Phase:
Study type: Observational [Patient Registry]

Ulcerative Colitis (UC) is a disease known for repeated relapses and remissions. So, meticulous follow-up is required to individualize treatment plans according to the status of each patient. The currently used investigations are invasive, costy, and carry the risk of several side effects, making it difficult for the patient to adhere to his continuous follow-up. Aim: To evaluate the viability of fecal lactoferrin, serum ferritin, and IL6 as noninvasive markers for detecting the activity and follow-up the patients of ulcerative colitis during remission.

NCT ID: NCT04647578 Not yet recruiting - Crohn Disease Clinical Trials

Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis

MICI-FIT
Start date: December 2022
Phase:
Study type: Observational

Inflammatory bowel diseases (IBDs), including Crohn's disease (CD), ulcerative colitis (UC) and IBD-unclassified (IBD-U), are characterised by chronic inflammation of the gastrointestinal tract. Over the past 50 years, the incidence of IBD has increased globally, with the highest increase in industrialised countries. During the last 25 years, the incidence of IBD has increased dramatically among teenagers in northern France, with an increase of 126% and 156% for CD and UC, respectively. Physical fitness is a set of attributes related to a person's ability to perform physical activities that require aerobic capacity, endurance, strength or flexibility and is determined by a combination of regular physical activity and genetically inherited ability. Physical fitness, widely recognised as an important health determinant, plays an important role in growth and development. Due to the evidence-based importance of physical fitness for young people's health status, attention should be paid to the assessment of physical fitness at these ages and whatever the health status. At this time, there is no study on the assessment of physical fitness in IBD pediatric patient.

NCT ID: NCT04408703 Not yet recruiting - Ulcerative Colitis Clinical Trials

PRognOstiC valuE of rEd Density in Ulcerative Colitis

PROCEED-UC
Start date: June 2020
Phase:
Study type: Observational

Observational prospective multicenter study: baseline assessement of the disease activity by an automated endoscopic tool and follow up of 52 weeks to evaluate sustained clinical remission.

NCT ID: NCT04332328 Not yet recruiting - Clinical trials for Diet in Ulcerative Colitis Patients

Study of Demographic and Dietary Profile in Patients With Ulcerative Colitis in Upper Egypt

Start date: April 1, 2020
Phase:
Study type: Observational

Diet is known to play role in the complex etiology of UC.Patient with UC tend to adapt unguided dietary habits without the guidance of a dietician or physician (Dejong,M.J 2019).so identification of nutritional gaps is needed to facilitate the development of evidence-based dietary guideline and subsequently give correct dietary advice to UC patients(Haskkey,N et al 2017).